The Perth Blood Institute

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Multiple myeloma1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 32 trials
• Phase 1/21 trial

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC1 trial
• Loxo Oncology, Inc.1 trial
• Syntara1 trial

Running trials

• Recruiting

  A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  NCT05254743· Phase 3· Loxo Oncology, Inc.· Source

  Contact: Ross Baker (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic lymphocytic leukaemia1 recruiting

Closed trials

• Completed

  Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis

  NCT04676529· Phase 1/2· Syntara· Source

• Completed

  A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

  NCT03301220· Phase 3· Janssen Research & Development, LLC· Source